Emerging Diseases

Top Story

10% of patients with candidemia have history of injection drug use

November 14, 2019
FDA News

FDA fast tracks nanatinostat combination for Epstein-Barr virus-associated lymphoma

November 13, 2019
The FDA granted fast track designation to nanatinostat in combination with valganciclovir for the treatment of relapsed or refractory Epstein-Barr virus-positive…
Breaking News

In a first, WHO prequalifies Merck’s Ebola vaccine

November 12, 2019
One day after winning conditional approval in Europe, Merck’s Ebola vaccine received prequalification status from WHO, giving it the agency’s stamp of…
FDA News

European Union conditionally approves Merck’s Ebola vaccine, Ervebo

November 11, 2019
The European Commission granted conditional approval for Ervebo, Merck’s investigational Ebola virus vaccine, which has been used widely and effectively in the…
More Headlines »

Invasive Fungal Infections: Diagnosis, Treatment, and Prophylaxis

This activity is supported by an educational grant from Astellas.

Invasive fungal infections (IFIs) represent a serious complication that frequently affects immunocompromised patients…
More »
At Issue

Was it the right decision to introduce a second vaccine in the DRC Ebola outbreak?

Infectious Disease News, October 2019
For more than a year, only Merck’s investigational V920 vaccine was used in the Ebola outbreak in the Democratic
More »
Meeting News

VIDEO: E. coli outbreak in rural community linked to bull manure

April 22, 2018
More »